TY  - CHAP
M1  - Book, Section
TI  - PREVENTING AND MITIGATING SMOKING-RELATED HEART DISEASE
A1  - Kalkhoran, Sara
A1  - Glantz, Stanton
A2  - Fuster, Valentin
A2  - Harrington, Robert A.
A2  - Narula, Jagat
A2  - Eapen, Zubin J.
Y1  - 2017
N1  - 
T2  - Hurst's The Heart, 14e
AB  - SummaryThis  chapter  discusses  the  prevention  of  smoking-related  heart  disease.  Smoking  cessation  results  in  an  immediate  reduction  in  risk  of  cardiac  events,  which  continues  to  decline  rapidly.  For  example,  the  smoking-related  excess  risk  of  myocardial  infarction  is  halved  by  a  year  after  smoking  cessation.  The  US  Public  Health  Service  recommends  that  all  patients  be  asked  about  their  tobacco  use  on  a  regular  basis  and  that  those  patients  who  do  smoke  are  advised  to  quit  and  are  assisted  in  quitting  (see  accompanying  Hurst’s  Central  Illustration).  Notably,  intensive  physician  advice  to  quit  smoking  is  associated  with  a  higher  rate  of  smoking  cessation  than  no  or  minimal  advice  to  quit.  Pharmacotherapy  and  counselling  are  effective  treatments  for  smoking  cessation,  particularly  when  combined.  First-line  pharmacotherapies  include  nicotine-replacement  therapy  (available  in  the  form  of  patches,  gum,  lozenges,  inhalers,  and  nasal  sprays),  varenicline,  and  bupropion.  The  efficacy  of  electronic  cigarettes  (e-cigarettes)  for  smoking  cessation  and  their  long-term  health  effects  are  not  well  established,  and  “real  world”  data  indicate  that  these  devices  are  associated  with  less  quitting  than  nicotine-replacement  therapy  or  no  cessation  aids.  Tobacco  control  policies,  such  as  smoke-free  workplaces  and  public  places,  have  had  a  substantial  role  in  reducing  smoking  prevalence  as  well  as  exposure  to  secondhand  smoke  in  countries  such  as  the  United  States  and  the  United  Kingdom.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesscardiology.mhmedical.com/content.aspx?aid=1191187223
ER  -